DUBLIN, March 14, 2018 /PRNewswire/ --
The "Anti-Parkinson's Drugs: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering.
This research report categorizes the anti-Parkinson's drugs market by type. Product types include low dopaminergic, dopamine agonists, enzyme inhibitors and other anti-Parkinson's medications.
Report Includes:
- An overview of the global market for anti-Parkinson's drugs and their future demand
- Analyses of global market trends, with data from 2013-2017, and projections of compound annual growth rates (CAGRs) through 2022
- Analyses of the major factors and technological advances such as biomarkers, 3D printed drugs, mobile applications and wearable technologies in the monitoring and treatment of Parkinson's disease
- Discussion of the major segments of the anti-Parkinson's drugs, i.e., dopaminergic drugs, dopamine agonists, enzyme inhibitors and other anti-Parkinson's medications
- Company profiles of the major players in the market, including AbbVie, Mylan Laboratories, Valeant Pharmaceuticals and Novartis
Key Highlights:
- The global anti-Parkinson's drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1%, from 2017 to 2022.
- Asia Pacific anti-Parkinson's drugs market is expected to grow from $1.0 billion in 2017 to $1.4 billion in 2022 at a CAGR of 6.4% for the period 2017-2022.
- North American anti-Parkinson's drugs market is expected to grow from $1.3 billion in 2017 to $1.8 billion in 2022 at a CAGR of 7.0% for the period 2017-2022.
Key Topics Covered:
1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Related Research Reports
2 Summary and Highlights
3 Anti-Parkinson's Drugs Market Characteristics
4 Anti-Parkinson's Drugs Market Size and Growth
- Historic Market Growth
- Drivers of the Market
- Restraints on the Market
- Forecast Market Growth
- Drivers of the Market
- Restraints on the Market
5 Anti-Parkinson's Drugs Market Trends and Strategies
- New Medication to Help the Body Absorb Parkinson's Disease Medication
- Free Water Biomarker to Track Changes in Brain
- 3D Printing Technology
6 PESTLE Analysis
- Political
- Government Financial Support
- Uncertain Political Policies
- Government Intervention
- Economic
- Wealth
- Globalization
- Emerging Markets
- Social
- Aging Global Population
- Health Consciousness and Awareness
- Traditional Medicine Continues to Pose Threat to Market
- Shortage of Skill
- Technological
- Technological Breakthroughs
- Wearable Technology and Hardware Advancements
- Internet Penetration and Mobile Applications
- Legal
- Stringent Regulations and Long Approval Procedures
- Tax Exemptions Initiatives and Subsidies
- Investment Regulations
- Environmental
7 Anti-Parkinson's Drugs Market Segmentation
- Global Anti-Parkinson's Drugs Market, by Segment
- Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Dopaminergics Market
- Market Characteristics
- Market Trends and Strategies
- Dopamine Agonists Market
- Market Characteristics
- Market Trends and Strategies
- Enzyme Inhibitors Market
- Market Characteristics
- Market Trends and Strategies
- Other Anti-Parkinson's Medications Market
- Market Characteristics
8 Anti-Parkinson's Drugs Market Regional and Country Analysis
- Global Anti-Parkinson's Drugs Market, by Region
- Global Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Region
- Global Anti-Parkinson's Drugs Market Segmentation, by Region, 2017
- Global Anti-Parkinson's Drugs Market, by Country
- Global Anti-Parkinson's Drugs Market, Historic and Forecast, by Country
- Global Anti-Parkinson's Drugs Market Segmentation, 2017, by Country
9 Global Anti-Parkinson's Drugs Market Comparison with Macro Economic Factors
- Global Per Capita Average Anti-Parkinson's Drugs Market Expenditure
- Per Capita Average Anti-Parkinson's Drugs Market Expenditure, by Country
10 Asia-Pacific Anti-Parkinson's Drugs Market
- Asia-Pacific Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Asia-Pacific Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Asia-Pacific Anti-Parkinson's Drugs Market Forecast Market
- Asia-Pacific Anti-Parkinson's Drugs Market, by Segment
- Asia-Pacific Anti-Parkinson's Drugs Market, Historic and Forecast CAGR, by Segment
11 Asia-Pacific Anti-Parkinson's Drugs Market: Country Analysis
- China Anti-Parkinson's Drugs Market Overview
- Country Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- China Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- China Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- China Market Size, by Segment
- China Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- India Anti-Parkinson's Drugs Market Overview
- Country Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Import and Export Duties
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- India Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- India Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- India Market Size, by Segment
- India Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Japan Anti-Parkinson's Drugs Market Overview
- Country Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Import and Export Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Japan Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Japan Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Japan Market Size, by Segment
- Japan Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Australia Anti-Parkinson's Drugs Market
- Australia Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Australia Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Australia Market Size, by Segment
- Australia Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
12 Western Europe Anti-Parkinson's Drugs Market
- Western European Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Western Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
- Western Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Western Europe Market Size, by Segment
- Western Europe Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
13 Western Europe Anti-Parkinson's Drugs Market: Country Analysis
- UK Anti-Parkinson's Drugs Market Overview
- Country Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- UK Anti-Parkinson's Drugs Historic Market, 2013-2017
- UK Anti-Parkinson's Drugs Forecast Market, 2017-2022
- UK Market Size, by Segment
- UK Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- Germany Anti-Parkinson's Drugs Market
- Germany Anti-Parkinson's Drugs Historic Market, 2013-2017
- Germany Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Germany Market Size, by Segment
- Germany Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
- France Anti-Parkinson's Drugs Market
- France Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- France Anti-Parkinson's Drugs Forecast Market, 2017-2022
- France Market Size, by Segment
- France Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
- Italy Anti-Parkinson's Drugs Market
- Italy Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Italy Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Italy Market Size, by Segment
- Italy Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022,
- Spain Anti-Parkinson's Drugs Market
- Spain Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- Spain Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Spain Market Size, by Segment
- Spain Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
14 Eastern Europe Anti-Parkinson's Drugs Market
- Eastern European Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Export and Import Duties On Anti-Parkinson Drugs
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- Eastern Europe Anti-Parkinson's Drugs Historic Market, 2013-2017
- Eastern Europe Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Eastern Europe Market Size, by Segment
- Eastern Europe Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
15 Eastern Europe Anti-Parkinson's Drugs Market: Country Analysis
- Russia Anti-Parkinson's Drugs Market
- Russia Anti-Parkinson's Drugs Historic Market, 2013-2017
- Russia Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Russia Market Size, by Segment
- Russia Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
16 North America Anti-Parkinson's Drugs Market
- North America Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- North America Anti-Parkinson's Drugs Historic Market, 2013-2017
- North America Anti-Parkinson's Drugs Forecast Market, 2017-2022
- North America Market Size, by Segment
- North America Anti-Parkinson's Drugs Market, Historic and Forecast, by Segment, 2013-2022
17 North America Anti-Parkinson's Drugs Market: Country Analysis
- USA Anti-Parkinson's Drugs Market
- USA Anti-Parkinson's Drugs Market Historic Market, 2013-2017
- USA Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- USA Market Size, by Segment
- USA Anti-Parkinson's Drugs Market, 2013-2022, Historic and Forecast, by Segment
18 South America Anti-Parkinson's Drugs Market
- South America Anti-Parkinson's Drugs Market Overview
- Region Information
- Market Information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulatory Bodies
- Regulations
- Major Associations
- Taxes Levied
- Corporate Tax Structure
- Competitive Landscape
- South America Anti-Parkinson's Drugs Historic Market, 2013-2017
- South America Anti-Parkinson's Drugs Forecast Market, 2017-2022
- South America Market Size, by Segment
- South America Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
19 South America Anti-Parkinson's Drugs Market: Country Analysis
- Brazil Anti-Parkinson's Drugs Market
- Brazil Anti-Parkinson's Drugs Historic Market, 2013-2016
- Brazil Anti-Parkinson's Drugs Market Forecast Market, 2017-2022
- Brazil Market Size, by Segment
- Brazil Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
20 Middle East Anti-Parkinson's Drugs Market
- Middle Anti-Parkinson's Drugs Market Overview
- Region Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Major Contracts/Research and Development Projects
- Regulations
- Regulatory Bodies
- Major Associations
- Competitive Landscape
- Middle East Anti-Parkinson's Drugs Historic Market, 2013-2017
- Middle East Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Middle East Market Size, by Segment
- Middle East Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
21 Africa Anti-Parkinson's Drugs Market
- Africa Anti-Parkinson's Drugs Market Overview
- Region Information
- Market information
- Prevalence of Parkinson's Disease
- Government Initiatives
- Regulatory Bodies
- Major Associations
- Export and Import Duties on Anti-Parkinson Drugs
- Competitive Landscape
- Africa Anti-Parkinson's Drugs Historic Market, 2013-2017
- Africa Anti-Parkinson's Drugs Forecast Market, 2017-2022
- Africa Market Size, by Segment
- Africa Anti-Parkinson's Drugs Historic and Forecast Market, by Segment, 2013-2022
22 Anti-Parkinson's Drugs Market Customer Information
- Significant Impact of Parkinson's Disease on Quality of Life
- Knowledge Gaps among Parkinson's Patients and Caregivers
- Parkinson's Awareness in UK
- Knowledge on Parkinson's Disease among Patients and General Neurologists
- Power of Placebo
23 Anti-Parkinson's Drugs Market Competitive Landscape
- Company Profiles
- ABBVIE
- BOEHRINGER INGELHEIM
- F. HOFFMANN-LA ROCHE AG
- NOVARTIS AG
- UCB SA
24 Key Mergers and Acquisitions in the Anti-Parkinson's Drugs Market
- Teva Pharmaceutical Acquired Auspex Pharmaceuticals
- Mitsubishi Tanabe Acquired NeuroDerm
- Sunovion Pharmaceuticals Acquired Cynapsus Therapeutics
- Acorda Therapeutics Acquired Civitas Therapeutics
- Acorda Therapeutics Acquired Biotie Therapies
25 Appendix
- Definitions of the Industry
- Anti-Parkinson's Drugs
- Research Methodology
26 References
For more information about this report visit https://www.researchandmarkets.com/research/5wzz38/global?w=5
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article